Skip to content

A randomized controlled clinical study of laparoscopic radical resection for right sided colon cancer and right gastroepiploic vascular lymph node

A randomized controlled clinical study of laparoscopic radical resection for right sided colon cancer and right gastroepiploic vascular lymph node

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042014
Enrollment
Unknown
Registered
2021-01-12
Start date
2019-01-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Right sided colon cancer

Interventions

The experimental group:Lymph nodes of the right gastroepiploid vessel were dissected
The control group:Without Lymph nodes of the right gastroepiploid vessel dissection

Sponsors

Colorectal Department, Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The clinical stage of patients with colon adenocarcinoma was stage II-III; 2. Patients with tumors located in ileocecal region, ascending colon and hepatic flexure colon; 3. Patients who have not received anti-tumor treatment before operation, including chemotherapy, radiotherapy, radiotherapy and chemotherapy; 4. Male and female patients, aged 18-75 years old; 5. Subjects with ECoG physical status of 0-2 points; 6. Patients with expected survival time > 6 months; patients who can cooperate to observe adverse reactions and curative effects.

Exclusion criteria

Exclusion criteria: 1. For the subjects with AST and / or ALT > 2.5 * ULN, serum total bilirubin > 1.5 * ULN; 2. The absolute count of neutrophil (ANC) was less than 1.5 * 10 ^ 9 / L, or platelet was less than 75 * 10 ^ 9 / L, or Hb was less than 90g / L; 3. Subjects with Cr > 1.5 * ULN; 4. Subjects with the second primary malignant tumor in the past five years, except for skin basal cell carcinoma or cervical carcinoma in situ after adequate treatment; 5. Subjects with any of the following diseases within 12 months before enrollment: myocardial infarction, severe / unstable angina pectoris, coronary / peripheral artery bypass grafting, symptomatic congestive heart failure or cerebrovascular accident; 6. Subjects with positive serum HIV antibody; 7. Subjects currently participating in other clinical trials; 8. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Lymph node metastasis rate of right gastroomentum vessel;

Secondary

MeasureTime frame
Number of right gastric omentum vascular lymph nodes;

Countries

China

Contacts

Public ContactLin Junzhong

Sun Yat-Sen University Cancer Center

linjzh@sysucc.org.cn+86 13802446666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026